Remove DNA Remove Gene Editing Remove Generic Pharmaceutical
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

5) Lynparza (Olaparib) Lynparza is a PARP inhibitor , meaning it inhibits poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. Additionally, Bayer has formed a partnership with Mammoth Biosciences to broaden its product portfolio with innovative gene-editing technology. Teva Pharmaceutical Industries Ltd.

Sales 98